Menetelmä diklofenaakkiin ja tobramysiiniin perustuvan silmätippaliuoksen valmistamiseksi
The ophtalmic solution comprises (a) the equivalent to 0.001-0,14 % of Diclofenac itself or an isomer, or a derivative or one of the pharmaceuticaly acceptable salts thereof; (b) the equivalent to a value of 0.001-0.45 % of Tobramicine, obtained from Tobramicine itself or from an isomer or a derivat...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Finnish Swedish |
Published |
31.03.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The ophtalmic solution comprises (a) the equivalent to 0.001-0,14 % of Diclofenac itself or an isomer, or a derivative or one of the pharmaceuticaly acceptable salts thereof; (b) the equivalent to a value of 0.001-0.45 % of Tobramicine, obtained from Tobramicine itself or from an isomer or a derivative or one of its pharmaceutically acceptable salts thereof; (c) optionally a solubilizer, an isotonizer, a pH damper, a viscosizer, a chelator, a preserving agent, and/or an excipient for pharmaceutical hydrogels. Application to the treatment of ocular and otic inflammations and/or infections. |
---|---|
Bibliography: | Application Number: FI19960000232 |